三個皮匠報告
政策庫
new
付費
搜索

已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理-行業數據

已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理
目前，國內市場上已上市的多發性骨髓瘤治療藥物主要有海特生物的埃普奈明、強生的達雷妥尤單抗、德琪醫藥的塞利尼索、安進/百濟神州的卡非佐米，以及硼替佐米、泊馬度胺、伊沙佐米、來那度胺等。
行業數據 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?26KB 圖片尺寸：2315*1322
同報告圖片
 / 25
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第1頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第2頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第3頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第4頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第5頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第6頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第7頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第8頁
fCDoja/niakgICAgICAgfCDkvIHkuJogICAgICAgICB8IOmAguW6lOeXhyAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IOWMu+S/neebruW9leaDheWGtSAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18Cnwg5Z+D5pmu5aWI5piOICAgIHwg5rW354m555Sf54mpICAgICB8IOiBlOWQiOaymeWIqeW6puiDuuWSjOWcsOWhnuexs+advueUqOS6juaXouW+gOaOpeWPl+i/h+iHs+WwkTLnp43ns7vnu5/mgKfmsrvnlpfmlrnmoYjnmoTlpI3lj5HmiJbpmr7msrvmgKflpJrlj5HmgKfpqqjpq5PnmKTmiJDkurrmgqPogIUgICAgICB8IOmihOiuoeaWsOWinuiNr+WTgeiwiOWIpCAgICAgICAgICAgICAgICAgICAgICAgfAp8IOehvOabv+S9kOexsyAgICB8IOm9kOmygeWItuiNr+etiSAgIHwg5aSa5Y+R5oCn6aqo6auT55ik44CB5aSN5Y+R5oCn5oiW6Zq+5rK75oCn5aWX57uG6IOe5reL5be055ik5oKj6ICFICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCDlt7LlnKjljLvkv53nm67lvZXkuK0gICAgICAgICAgICAgICAgICAgICAgICAgfAp8IOS8iuaymeS9kOexsyAgICB8IOatpueUsOWItuiNryAgICAgfCDlt7LmjqXlj5fov4foh7PlsJHkuIDnp43ml6LlvoDmsrvnlpfnmoTlpJrlj5HmgKfpqqjpq5PnmKTmiJDkurrmgqPogIUgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCDlt7LlnKjljLvkv53nm67lvZXkuK0gICAgICAgICAgICAgICAgICAgICAgICAgfAp8IOWNoemdnuS9kOexsyAgICB8IOWuiei/my/nmb7mtY7npZ7lt558IOWkjeWPkeaIlumavuayu+aAp+WkmuWPkeaAp+mqqOmrk+eYpOaIkOS6uuaCo+iAhe+8jOaCo+iAheaXouW+gOiHs+WwkeaOpeWPl+i/hzLnp43msrvnlpfvvIzljIXmi6zom4vnmb3phbbkvZPmipHliLbliYLlkozlhY3nlqvosIPoioLliYIgICAgIHwg5Zyo5Yy75L+d55uu5b2V5Lit77yM5pys5qyh55Sz6K+36LCD5pW05pSv5LuY6IyD5Zu0ICAgICAgICB8Cnwg5p2l6YKj5bqm6IO6ICAgIHwg5q2j5aSn5aSp5pm0562JICAgfCDkuI7lnLDloZ7nsbPmnb7ogZTnlKjvvIzmsrvnlpfmraTliY3mnKrnu4/msrvnlpfkuJTkuI3pgILlkIjmjqXlj5fnp7vmpI3nmoTlpJrlj5HmgKfpqqjpq5PnmKTmiJDlubTmgqPogIUgICAgICAgICAgICAgICAgICAgICAgICB8IOW3suWcqOWMu+S/neebruW9lSAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgIHwgICAgICAgICAgICAgIHwg5LiO5p2l6YKj5bqm6IO65ZKM5Zyw5aGe57Gz5p2+6IGU5ZCI55So6I2v5oiW5aSa5Y+R5oCn6aqo6auT55ik5oiQ5bm05oKj6ICFICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IOayu+mprOW6puiDuiAgICB8IOm9kOmygeWItuiNr+etiSAgIHwg5pei5b6A5o6l5Y+X6L+H6Iez5bCR5Lik56eN5rK755aX77yI5YyF5ous5p2l6YKj5bqm6IO65ZKM5LiA56eN6JuL55m96YW25L2T5oqR5Yi25YmC77yJ77yM5LiU5Zyo5pyA5ZCO5LiA5qyh5rK755aX5pyf6Ze05oiW5rK755aX5ZCONjDlpKnlhoXlj5HnlJ/nlr7nl4Xov5vlsZXnmoTmiJDlubTlpJrlj5HmgKfpqqjpq5PnmKTmgqPogIUgfCDlt7LlnKjljLvkv53nm67lvZUgICAgICAgICAgICAgICAgICAgICAgICAgICB8Cnwg6L6+6Zu35aal5bCk5Y2V5oqXfCDlvLrnlJ8gICAgICAgICB8IOWNleiNr+ayu+eWl+WkjeWPkeWSjOmavuayu+aAp+WkmuWPkeaAp+mqqOmrk+eYpOaIkOW5tOaCo+iAhe+8jOaCo+iAheaXouW+gOaOpeWPl+i/h+WMheaLrOibi+eZvemFtuS9k+aKkeWItuWJguWSjOWFjeeWq+iwg+iKguWJgueahOayu+eWl+S4lOacgOWQjuS4gOasoeayu+eWl+aXtuWHuueOsOeWvueXhei/m+WxlSB8IOW3suWcqOWMu+S/neebruW9lSAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCDotZvliKnlsLzntKIgICAgfCDlvrfnkKrljLvoja8gICAgIHwg5pei5b6A5o6l5Y+X6Iez5bCRMue6v+ezu+e7n+aAp+ayu+eWl+WQju+8jOWkjeWPkeaAp+aIlumavuayu+aAp+W8pea8q+aAp+Wkp0Lnu4bog57mt4vlt7TnmKTvvIhETEJDTO+8ie+8jOWMheaLrOeUsea7pOazoeaAp+a3i+W3tOeYpOi9rOWMlueahERMQkNM5oiQ5Lq65oKj6ICFIHwg6aKE6K6h5paw5aKe6YCC5bqU55eH6LCI5YikICAgICAgICAgICAgICAgICAgICAgIHwKfCAgICAgICAgICAgIHwgICAgICAgICAgICAgIHwg5pei5b6A5o6l5Y+X6L+H5rK755aX5LiU5a+56Iez5bCR5LiA56eN6JuL55m96YW25L2T5oqR5Yi25YmC77yM5LiA56eN5YWN55ar6LCD6IqC5YmC5Lul5Y+K5LiA56eN5oqXQ0QzOOWNleaKl+mavuayu+eahOWkjeWPkeaIlumavuayu+aAp+WkmuWPkeaAp+mqqOmrk+eYpOaIkOS6uuaCo+iAhSB8IOW3suWcqOWMu+S/neebruW9lSAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWMu+S/neWxgCwgQ0RFLCDlm73mipXor4HliLjnoJTnqbbkuK3lv4M=
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第9頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第10頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第11頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第12頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第13頁
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
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第14頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第15頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第16頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第17頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第18頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第19頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第20頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第21頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第22頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第23頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第24頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第25頁
已在國內獲批上市多發性骨髓瘤藥物醫保談判情況梳理_第26頁
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
所屬報告： 創新藥研究框架之2024年醫保談判前瞻：國談進入常態化階段創新藥長期放量可期-241016（28頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站